Shop By
Catalog No.
Product Name
Application
Product Information
Citations
-
N-cadherin antagonist
Exherin is a small, cyclic pentapeptide vascular-targeting agent with potential antineoplastic and antiangiogenic activities.- Michelle S Huang, .et al. , Nat Commun, 2025, Jun 5;16(1):5213 PMID: 40473615
- Ariel Diaz, .et al. , J Cereb Blood Flow Metab, 2021, Mar 24 PMID: 33757316
- CM Madl, .et al. , Adv Sci, 2019, 1801716 PMID: 30828535
- Christopher M. Madl, .et al. , Nat Mater, 2017, Dec; 16(12): 1233-1242 PMID: 29115291
- Andrew J. Lindsay, .et al. , Oncotarget, 2017, Dec 1; 8(62): 104717-104732 PMID: 29285208
-
GPIIb/IIIa antagonist
Tirofiban, Hydrochloride Hydrate is a specific nonpeptide platelet fibrinogen receptor (GPIIb/IIIa) antagonist. -
NRP1 antagonist
EG01377 TFA salt is a selective neuropilin-1 (NRP1) antagonist. CAS: 2227996-00-9 (Free base) -
VKOR antagonist
Tecarfarin sodium (ATI-5923 sodium) is a novel orally active non-competitive vitamin K epoxide reductase (VKOR) antagonist, impairs the activation of the vitamin K-dependent clotting factors II, VII, IX and X. -
MC4 antagonist
SNT207858 is a 22 nM MC4 antagonist with a 170-fold selectivity vs. MC3 and a 40-fold selectivity versus MC5. -
cytoplasmic dynein antagonist
Ciliobrevin D is the first specific small molecule antagonist of cytoplasmic dynein -
pan-selectin antagonist
Bimosiamose is a pan-selectin antagonist, inhibits E-, P-, and L-selectin with IC50s of 88 μM, 20 μM, and 86 μM, respectively, and can be used in the research of inflammatory disease.
